Home

Strategic Financial Communication Consultant / Investor Relations

Mainly for biopharmaceuticals

  • Strategic review of company financial communication practices
  • Public speaking training for executives spokespersons
  • IR competencies upgrade for newly appointed Investor Relations Officer

Board

  •  Board member or board advisor

Lecturer

  • Increase awareness and understanding of biopharmaceutical companies challenges, in particular with regard its financial communication aspects

Financial Communication Consultant / Investor Relations

– Mainly for biopharmaceuticals

  • Strategic review of company financial communication practices
  • Public speaking training for executives spokespersons
  • IR competencies upgrade for newly appointed Investor Relations Officer

Board

  • Board member or board advisor

Lecturer

  • Increase awareness and understanding of biopharmaceutical companies challenges, in particular with regard its financial communication aspects

 Biopharmaceutical companies …

Biopharmaceutical companies …

Target audiences:
– CEO / CFO of startups and biotechs, listed or not

Objectives:

  • coach executives to improve the effectiveness of their financial communication (communication to capital markets regarding newsflow, financing / fundraising, perspectives etc.) by helping them to refine their communication strategy, prepare their roadshows and public speaking events, in English or French
  • advise boards on financial communication

 … and their ecosystem

Target audiences:
– VCs / investors, bankers
– biotech competitiveness clusters and incubators
– market operators
– financial communication agencies
– …

Objectives:

  • suggest or provide expertise to their clients / partners to develop companies skills in terms of financial communication / Investor Relations

Other activities from PM.Bringer Consulting

Other activities

Lecturer to institutions or media related to the Pharmaceutical Industry, as well as to Academia including Universities of Pharmacy (link only in French).

Promote awareness and better understanding of the challenges facing biopharmaceutical companies, in particular on aspects of its financing and financial communication.

Recent news

france-biotech-logo

PM. Bringer Consulting joins France Biotech and will attend the “commission Corporate Finance
4-Mai-2021
» See on LinkeIn

LinkedIn Carousel IRO

Listed biotech: Should you have your own internal Investor Relation Officer
21-Mar-2021
» See on LinkeIn

1616058218926

PM. Bringer attending 14th édition of the Forum des Métiers du Médicament (CEPhI – Strasbourg)
17-Mar-2021
» See brochure

BioFIT 2020: Dec. 8th session “How to differentiate as a potential partner on the crowded oncology playfield?”
01-Dec-2020
» BioFIT website

Article on Biotech Finances: Vade-Mecum pour une communication financière maitrisée
07-Nov-2020
» Read on Biotech Finances (in French)